Le Lézard
Classified in: Health
Subject: PER

American Addiction Centers Names Dr. Lawrence Weinstein as Chief Medical Officer


BRENTWOOD, Tenn., Aug. 14, 2018 /PRNewswire/ -- American Addiction Centers (AAC), a leading provider of inpatient and outpatient substance abuse treatment services, has appointed Dr. Lawrence M. Weinstein as its new chief medical officer. Starting August 13, Weinstein will oversee medical operations for all AAC facilities and supervise the medical staff to ensure all patients are receiving high-quality care. Dr. Weinstein brings more than 20 years' experience in psychiatry, addiction and managed care to his new role and an unwavering commitment to clinical excellence.

Dr. Lawrence Weinstein

"We are fortunate to have a physician of Dr. Weinstein's caliber serving as chief medical officer," said Michael Nanko, Ph.D., president and COO of American Addiction Centers. "Dr. Weinstein's extensive background in the clinical and operational aspects of behavioral health, as well as medical leadership, aligns with AAC's continued commitment to provide evidenced-based care and innovative treatment to our patients."

To learn more about American Addiction Centers' treatment centers, visit www.americanaddictioncenters.org.  

Dr. Weinstein most recently served as chief medical officer at Humana Behavioral Health, a position he held since 2011. During his tenure, he provided oversight for clinical management and played a key role in medical policy development, new technology assessments and practice guidelines. Prior to that role, he served as senior vice president of medical affairs for Catasys, Inc. in California, where he was a key player in the managed care and government provider marketplace. His career highlights also include serving as the regional medical director / senior plan officer for the department of managed health care at PacifiCare Behavioral Health in California, where he directed the development and delivery of quality medical services to more than 4 million people.

"My main focus will be on the patients that entrust their care to AAC," said Dr. Weinstein. "I want them to receive the best possible care and the same outstanding experience, regardless of the facility in which they receive treatment. By infusing a clinical quality mindset throughout the organization, patient outcomes will continue to improve and AAC will remain at the forefront of addiction treatment."

The announcement of Dr. Weinstein's appointment to chief medical officer coincides with the news that AAC's current national medical director, Dr. Mark Calarco, has been promoted to national medical director for clinical diagnostics. In this role, Dr. Calarco will work closely with Addiction Labs to conduct medical and laboratory research as well as develop innovative products and services that will improve patient outcomes. He will also focus on establishing key partnerships to expand laboratory operations.

About American Addiction Centers
American Addiction Centers is a leading provider of inpatient and outpatient substance abuse treatment services. We treat clients who are struggling with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at AmericanAddictionCenters.org or follow us on Twitter @AAC_Tweet.

Media Contact
Joy Sutton, PR Manager
American Addiction Centers
[email protected]
615-587-7728

SOURCE American Addiction Centers


These press releases may also interest you

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...

at 12:01
Election of the board of directors and auditor The annual general meeting in Orexo AB (publ) on 26 April 2024 resolved, in accordance with the nomination committee's proposal, that the number of board members shall be five with no deputy board...

at 12:00
Cupid Lipstm, under the leadership of renowned Beverly Hills facial plastic surgeon Dr. Ben Talei, has been honored as a top patient-rated destination for lip lift...



News published on and distributed by: